Saturday, August 22, 2015
Takeda and Nanotherapeutics Announce Agreement to Expand Takeda’s Commercialization and Technology Access Rights in Support of Influenza and Other Vaccine Programs

Takeda Pharmaceutical Company Limited and Nanotherapeutics, Inc., announced an agreement providing Takeda with expanded commercialization and technology access rights related to Nanotherapeutics’ Vero cell technology platform – a cell culture-based platform for vaccine production which Nanotherapeutics acquired from Baxalta, formerly Baxter International’s BioScience division. ..

Read More
Friday, July 10, 2015
Nanotherapeutics Awarded BARDA Fill-Finish Manufacturing Network Task Orders to Develop Two FDA Drug Shortage Products

Nanotherapeutics, Inc. announced that it has received two new Task Orders from The United States Department of Health and Human Services (HHS), Biomedical Advanced Research and Development Authority (BARDA) Fill-Finish Manufacturing Network’s (FFMN) Pilot Production program, for the Center for Drug Evaluation and Research (CDER) pathway regulated products. ..

Read More
Tuesday, May 19, 2015
Growth in biotech trade show mirrors growing industry

Signs of a growing biotech industry could be seen in all directions during the 12th annual BioFlorida Celebration of Biotechnology on the grounds of RTI Surgical at Progress Park. ..

Read More
Wednesday, October 23, 2013
Nanotherapeutics Celebrates Groundbreaking of its Advanced Development and Manufacturing Center

he city of Alachua's past, present and future were on display Wednesday morning as Nanotherapeutics broke ground on a 165,000-square-foot facility on the grounds of the former Copeland Sausage plant. ..

Read More
Wednesday, June 22, 2011
Nanotherapeutics Gets FDA Orphan-Drug Status for NanoDTPA™ Capsules to Treat Radiation Exposure

DA approves orphan-drug designation to Nanotherapeutics' new oral capsule under development for treatment of radiation exposure. NanoDTPA™ capsule is one of several products the company is developing for chemical, biological, radiological and nuclear (CBRN) medical countermeasures. ..

Read More